A Natural History Study of Patients With G2019S LRRK2 Parkinson's Disease

NCT05349019 · clinicaltrials.gov ↗

TERMINATED

Status

22

Enrollment

INDUSTRY

Sponsor class

Stopped Sponsor stopped the study

Conditions

Patients With Parkinson's Disease (PD) Caused by the p.Gly2019Ser (G2019S) Pathogenic Mutation of the Leucine-Rich Repeat Kinase 2 (LRRK2) Gene

Interventions

OTHER: Observational

Sponsor

Escape Bio, Inc.

Collaborators

[object Object]
[object Object]